Evaluation of Fbxw7 expression and its correlation with the expression of c-Myc, cyclin E and p53 in human hepatocellular carcinoma-Reference-Cited by-同舟云学术

Evaluation of Fbxw7 expression and its correlation with the expression of c-Myc, cyclin E and p53 in human hepatocellular carcinoma

Published:2012-04-30 Issue:9 Volume:42 Page:904-910
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:

Author:

Tu Kangsheng,Zheng Xin,Zan Xianfeng,Han Shaoshan,Yao Yingmin,Liu Qingguang

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Reference24 articles.

1. Accelerated expression of a Myc target gene Mina53 in aggressive hepatocellularcarcinoma;Ogasawara;Hepatol Res,2010

2. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma;Tabor;J Med Virol,1994

3. Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis;Caselmann;J Hepatol,1995

4. Cellular and molecular mechanisms of hepatocarcinogenesis;Rogler;Semin Liver Dis,1992

5. Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression;Kawate;Oncology,1999

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of FBXW7 loss of function in human cancers;Molecular Cancer;2022-03-26

2. Attenuating glucose metabolism by Fbxw7 promotes Taxol sensitivity of colon cancer cells through downregulating NADPH oxidase 1 (Nox1);Annals of Translational Medicine;2021-05

3. Circular RNA hsa_circ_0001306 Functions as a Competing Endogenous RNA to Regulate FBXW7 Expression by Sponging miR-527 in Hepatocellular Carcinoma;Journal of Cancer;2021

4. The Long-To-Short-Axis Ratio and Multifocality are Associated With TP53 Mutation Status in Surgically Resected Hepatocellular Carcinomas;Academic Radiology;2020-12

5. Long non-coding RNA TINCR as potential biomarker and therapeutic target for cancer;Life Sciences;2020-09